Hongzhong Wu, Ph.D, MBA
Executive Director in Tasly Capital @ Tasly Pharmaceutica Group Co., Ltd.
About
Hongzhong Wu (Thomas Wu), Ph.D in Molecular Pharmacology from East China University of Science and Technology, MBA, Part-time instructor of Pharmacy Engineering in East China University of Science and Technology. Currently serves as the Executive Investment Director in Tasly Capital. Hongzhong's work experience include: 1. Drug discovery: assy development, in vivo efficacy evaluation, IND filing, project management 2. BD for drug development: Scouting, Evaluation, Value Forcast, TS Negotiatation, Deal Closing 3. Venture Captital & Private Equity: Opprotuntiy Identification, Evaluation, valuationg, DD, Negotiation, post-money management and Withdrawal.
China
Shanghai
Venture Capital & Private Equity
Pharmaceutical Industry, Drug Discovery, Life Sciences, Biotechnology, Drug Development, Assay Development, Molecular Biology, Cross-functional Team Leadership, Clinical Development, High Throughput Screening, CRO, Biochemistry, Technology Transfer, Preclincal drug development, Assay development: Kinase, GPCR, transporter, cellular assay development: stable cell line establishiment, cell viability test, BD for seeking potential clients, Oncology, Biopharmaceuticals, Cell Culture
Experience
Executive Director in Tasly Capital
Tasly Pharmaceutica Group Co., Ltd.
Shanghai City, China
Lead the investment of Huaxin Fund, a branch of Tasly Capital
Investment Director/BD Director
Zhejiang Huahai Pharmaceutical Co., Ltd
Shanghai City, China
1. Look for, evaluate and close the equity investment opportunity in pharmaceutical industy---Industry funds of Huahai Pharm 2.Monitor any potential new product in-licensing opportunity in the market, take the leading role to build up any collaboration with the partner. 3. Overview any new stargeties and trends on drug development for the company, provide suggestions for internal pipeline development. 4. Value prediction for early development or on-market products in licensing. 5. Look for and evaluate any potential M&A opportunities for the company.
Associate Director
HUYABIO International
Shanghai City, China
Project scouting, scientific liaison, due dilligence, data evaluation, BD, license in
Associate Director
Sundia MediTech Co., Ltd.
Shanghai City, China
Associate Director of in vitro bilogy, was responsible for assay development for compound screening, which include celluar assays (stable or transient, inducible or non inducible), kinases, GPCR, transporter.
Group Leader
ChemPartner
Shanghai City, China
Assay development for big pharmas, mange the integrated programs for clients, in vivo efficacy evaluation for anti-tumor drug candidates, PDX model establishment, diabetic drug development, BD
Education
East China University of Science and Technology
Bioengineering and pharmacology
Hongzhong Wu, Ph.D, MBA's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.